Arthrocutaneous disorders including Reiter's syndrome, psoriasiform rashes, and other forms of chronic arthritis and enthesopathy, such as psoriatic arthritis, occur with an increased prevalence in the setting of HIV infection. Herein we describe the spectrum and prevalence of musculoskeletal and allied skin disorders as they occur in the setting of HIV infection. The role of genetic susceptibility in the development of these disorders is addressed. Based on the frequency of infectious agents capable of triggering reactive arthritis and the presence of HLA-B27 in 71% of these individuals, it is suggested that the disorder strongly resembles Reiter's syndrome as it occurs in the not HIV-infected group. Preliminary evidence indicates an enhanced penetrance for susceptibility among HLA-B27 individuals. In contrast, among HIV-infected patients with psoriasiform lesions there was no statistically significant association (P<0.05) between the presence of psoriasiform rash and the HLA alleles Cw6, B7, B17, Bw16, or Bw57 when compared with HIV-infected controls. These findings suggest that among HIV-infected individuals the development of Reiter's syndrome involves an immune recognition event primarily dependent upon HLA-B27 molecules in which an unknown antigen in the context of HLA-B27 is presented to CD8 lineage suppressor/cytotoxic cells. In contrast, the pathogenesis of psoriasiform lesions in HIV patients, despite their similarity to certain lesions in Reiter's syndrome, proceeds by distinct pathways that do not involve events influenced by specific polymorphic class I molecules.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DCO, Sturrock RD (1973) Ankylosing spondylitis and HLA27. Lancet I:904
Fischer H, Solomon G, Enlow R, Winchester R (1985) Reiter's syndrome and the acquired immune deficiency syndrome. Arthritis Rheum (abstr)
Winchester R, Bernstein DH, Fischer HD, Enlow R, Solomon G (1987) The co-occurrence of Reiter's syndrome and acquired immunodeficiency. Ann Intern Med 106:19
Winchester R, Solomon G (1988) Reiter's syndrome and acquired immunodeficiency. In: Espinoza L, Goldenberg D, Arnett F, Alarcon G (eds) Infections in the rheumatic diseases. Grune and Stratton, Orlando, Fla, p 343
Rynes RI, Goldenberg D, Olsen R, Hussain M, Veazey J, DiGiacomo R (1987) Acquired immunodeficiency syndrome associated arthritis. Arthritis Rheum 30 (suppl 4):S37 (abstr)
Brancato LJ, Itescu S, Skovron ML, Mildvan D, Winchester RJ (1988) Arthritis, psoriasis and related syndromes associated with HIV infection. Clin Res 36:531A (abstr)
Espinoza LR, Berman A, Vasey FB, Cahalin C, Nelson R, Germain BF (1988) Psoriatic arthritis and acquired immunodeficiency syndrome. Arthritis Rheum 31:1034
Berman A, Espinoza LR, Aguillar JL, Rolando T, Vasey FB, Germain BF, Lockey RF (1988) Rheumatic manifestations of human immunodeficiency virus infection. Am J Med 85:59–64
Johnson TM, Duvic M, Rapini RP, Rios A (1985) AIDS exacerbates psoriasis (letter). N Engl J Med 313:1415
Kaplan MH, Sadick N, McNutt S, Meltzer M, Sarngadharan MG, Pahwa S (1987) Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS). J Am Acad Dermatol 16:485
Michet CJ, Machado EBV, Ballard DJ, McKenna CH (1988) Epidemiology of Reiter's syndrome in Rochester, Minnesota: 1950–1980. Arthritis Rheum 31:428
Aho K, Ahvonen PI, Alkio P et al (1975) HLA B27 in reactive arthritis following infection. Ann Rheum Dis 34 (suppl 1):29
Calin A, Fries JF (1976) An “experimental” epidemic of Reiter's syndrome revisited: follow-up evidence on genetic and environmental factors. Ann Intern Med 84:564
Paronen I (1948) Reiter's disease: a study of 344 cases observed in Finland. Acta Med Scand 131 (suppl 212):1
Khan MA, Van der Linden SM (1984) The risk of ankylosing spondylitis in HLA-B27 positive individuals: a reappraisal (editorial) J Rheumatol 11:727
Terasaki PI (ed) (1980) Histocompatibility testing 1980. UCLA Tissue Typing Laboratory, Los Angeles, Calif, p 711
Iversen OJ, Dalen AB (1983) Urine proteins cross-reacting with antiserum against virus-like particles from cultured psoriatic epithelial cells. Acta Pathol Microbiol Immunol Scand B91:343
Asbakk K, Iversen OJ (1988) Monoclonal antibodies against the major internal protein, p 27, of a psoriasis-associated retrovirus-like particle. Scand J Immunol 28:195–202
Iversen OJ, Rodahl E (1985) The major internal protein, p 27, of a retrovirus-like particle participates in immune complex formation in psoriasis. Arch Virol 86:37
Belsito DV, Sanchez MR, Baer RL, Valentine F, Thorbecke GJ (1984) Reduced Langerhans cell IA antigen and ATPase activity in patients with AIDS. N Engl J Med 310:1279
Mullins JF, Maberry JD, Stone OJ (1966) Reiter's syndrome treated with folic acid antagonists. Arch Dermatol 94:335
Farber GA, Forshner JG, O'Quinn SE (1967) Reiter's syndrome: treatment with methotrexate. JAMA 20:171
About this article
Cite this article
Brancato, L., Itescu, S., Skovron, M.L. et al. Aspects of the spectrum, prevalence and disease susceptibility determinants of Reiter's syndrome and related disorders associated with HIV infection. Rheumatol Int 9, 137–141 (1989). https://doi.org/10.1007/BF00271870
- HIV infection
- Reiter's syndrome